BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 29149414)

  • 1. Role of TCTP for Cellular Differentiation and Cancer Therapy.
    Seo EJ; Fischer N; Efferth T
    Results Probl Cell Differ; 2017; 64():263-281. PubMed ID: 29149414
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interaction of antihistaminic drugs with human translationally controlled tumor protein (TCTP) as novel approach for differentiation therapy.
    Seo EJ; Efferth T
    Oncotarget; 2016 Mar; 7(13):16818-39. PubMed ID: 26921194
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Translationally controlled tumor protein is a target of tumor reversion.
    Tuynder M; Fiucci G; Prieur S; Lespagnol A; Géant A; Beaucourt S; Duflaut D; Besse S; Susini L; Cavarelli J; Moras D; Amson R; Telerman A
    Proc Natl Acad Sci U S A; 2004 Oct; 101(43):15364-9. PubMed ID: 15489264
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Knockdown of translationally controlled tumor protein inhibits growth, migration and invasion of lung cancer cells.
    Wang L; Tang Y; Zhao M; Mao S; Wu L; Liu S; Liu D; Zhao G; Wang X
    Life Sci; 2018 Jan; 193():292-299. PubMed ID: 28970113
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Translational Controlled Tumour Protein TCTP: Biological Functions and Regulation.
    Bommer UA
    Results Probl Cell Differ; 2017; 64():69-126. PubMed ID: 29149404
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TCTP as therapeutic target in cancers.
    Acunzo J; Baylot V; So A; Rocchi P
    Cancer Treat Rev; 2014 Jul; 40(6):760-9. PubMed ID: 24650927
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biological models and genes of tumor reversion: cellular reprogramming through tpt1/TCTP and SIAH-1.
    Tuynder M; Susini L; Prieur S; Besse S; Fiucci G; Amson R; Telerman A
    Proc Natl Acad Sci U S A; 2002 Nov; 99(23):14976-81. PubMed ID: 12399545
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TCTP as a therapeutic target in melanoma treatment.
    Boia-Ferreira M; Basílio AB; Hamasaki AE; Matsubara FH; Appel MH; Da Costa CRV; Amson R; Telerman A; Chaim OM; Veiga SS; Senff-Ribeiro A
    Br J Cancer; 2017 Aug; 117(5):656-665. PubMed ID: 28751755
    [TBL] [Abstract][Full Text] [Related]  

  • 9. AMG900 as novel inhibitor of the translationally controlled tumor protein.
    Fischer N; Seo EJ; Klinger A; Fleischer E; Efferth T
    Chem Biol Interact; 2021 Jan; 334():109349. PubMed ID: 33259807
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lessons from tumor reversion for cancer treatment.
    Amson R; Karp JE; Telerman A
    Curr Opin Oncol; 2013 Jan; 25(1):59-65. PubMed ID: 23165143
    [TBL] [Abstract][Full Text] [Related]  

  • 11. History of Histamine-Releasing Factor (HRF)/Translationally Controlled Tumor Protein (TCTP) Including a Potential Therapeutic Target in Asthma and Allergy.
    MacDonald SM
    Results Probl Cell Differ; 2017; 64():291-308. PubMed ID: 29149416
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of the Translationally Controlled Tumor Protein (TCTP) Interactome Reveals Novel Binding Partners in Human Cancer Cells.
    Li S; Chen M; Xiong Q; Zhang J; Cui Z; Ge F
    J Proteome Res; 2016 Oct; 15(10):3741-3751. PubMed ID: 27607350
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aberrant expression of translationally controlled tumor protein (TCTP) can lead to radioactive susceptibility and chemosensitivity in lung cancer cells.
    Du J; Yang P; Kong F; Liu H
    Oncotarget; 2017 Nov; 8(60):101922-101935. PubMed ID: 29254214
    [TBL] [Abstract][Full Text] [Related]  

  • 14. RNA interference‑mediated knockdown of translationally controlled tumor protein induces apoptosis, and inhibits growth and invasion in glioma cells.
    Jin H; Zhang X; Su J; Teng Y; Ren H; Yang L
    Mol Med Rep; 2015 Nov; 12(5):6617-25. PubMed ID: 26328748
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel ligand of the translationally controlled tumor protein (TCTP) identified by virtual drug screening for cancer differentiation therapy.
    Fischer N; Seo EJ; Abdelfatah S; Fleischer E; Klinger A; Efferth T
    Invest New Drugs; 2021 Aug; 39(4):914-927. PubMed ID: 33492639
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phospho-TCTP as a therapeutic target of Dihydroartemisinin for aggressive breast cancer cells.
    Lucibello M; Adanti S; Antelmi E; Dezi D; Ciafrè S; Carcangiu ML; Zonfrillo M; Nicotera G; Sica L; De Braud F; Pierimarchi P
    Oncotarget; 2015 Mar; 6(7):5275-91. PubMed ID: 25779659
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Introduction: How We Encountered TCTP and Our Purpose in Studying It.
    Telerman A; Amson R
    Results Probl Cell Differ; 2017; 64():1-8. PubMed ID: 29149401
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Current Understanding of the TCTP Interactome.
    Li S; Ge F
    Results Probl Cell Differ; 2017; 64():127-136. PubMed ID: 29149405
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TCTP regulates genotoxic stress and tumorigenicity via intercellular vesicular signaling.
    Amson R; Senff-Ribeiro A; Karafin T; Lespagnol A; Honoré J; Baylot V; Banroques J; Tanner NK; Chamond N; Dimitrov JD; Hoebeke J; Droin NM; Job B; Piard J; Bommer UA; Choi KW; Abdelfatah S; Efferth T; Telerman SB; Geyer FC; Reis-Filho J; Telerman A
    EMBO Rep; 2024 Apr; 25(4):1962-1986. PubMed ID: 38548973
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Translationally controlled tumor protein induces epithelial to mesenchymal transition and promotes cell migration, invasion and metastasis.
    Bae SY; Kim HJ; Lee KJ; Lee K
    Sci Rep; 2015 Jan; 5():8061. PubMed ID: 25622969
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.